Drawing for SIGI

USPTO serial 79322090

SIGI

Reviewed by CopyMark Law Group

Reg. 7102302Status 700Registered
Filing date
Status date
Registration date
Jul 11, 2023
Examiner
MAHMOUDI, MARIAM AZIZ
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SIGI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Louis K. Ebling

Louis K. Ebling Thompson Hine LLP312 Walnut Street, Suite 2000Cincinnati, OH 45202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable and recorded software for use in medication delivery systems for controlling medicament delivery in the field of diabetes management; downloadable software for use in infusion patch pump systems for diabetes management; downloadable software in the form of applications for mobile telephones, laptops and portable electronic devices, said software for use in user authentication and secure data transmission online and controlling pumps for medical useACTIVE—
010Medical fluid injectors, namely, injectors for transcutaneous delivery of medication including insulin; pumps for medical use, namely, wearable patch pumps sold empty for transcutaneously delivering medication for diabetes management; replacement parts and accessories specifically adapted for pumps for medical use, namely, replacement caps for microdosing, cannula applicators, adhesive pads, and transcutaneous cannulas; medicine administering devices, namely, infusion and injection devices for administering drugs; portable subcutaneous drug delivery devices, namely, drug delivery ports and pumps for delivering drugs beneath the skin; infusion pumps; devices for diabetes management, namely, insulin patch pumps sold empty; insulin pumpsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 31, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 11, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 11, 2023FIMPFINAL DISPOSITION PROCESSED—
Oct 11, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 11, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 11, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 16, 2023GPNXNOTIFICATION PROCESSED BY IB—
May 6, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 25, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 25, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 5, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 5, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 5, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 29, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 21, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 21, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Mar 21, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 21, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 21, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 8, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 8, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 1, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 1, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 1, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Feb 1, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 1, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 1, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 4, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 4, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 4, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 23, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 23, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 23, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 24, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 26, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 26, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 26, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 26, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 26, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 22, 2022RFNTREFUSAL PROCESSED BY IB—
May 26, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 26, 2022RFRRREFUSAL PROCESSED BY MPU—
Apr 23, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 22, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 18, 2022DOCKASSIGNED TO EXAMINER—
Oct 16, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 12, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 7, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance